Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407029 · ClinicalTrials.gov registry record
R3® Acetabular System in Patients With Degenerative Hip Disease
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 158
- Enrollment target
NCT01407029: Completed study, sponsored by Smith & Nephew.
NCT01407029 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01407029 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized, consecutive series, multicenter clinical study that will include patients who will have total hip replacement with the R3 Acetabular System.
Primary Outcome
The objective of this study is to establish the safety and effectiveness of the R3 Acetabular System in primary total hip replacement.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2009-10 |
| Est. Completion | 2017-03-14 |
What the finished NCT01407029 record still lists
NCT01407029 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01407029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01407029 about?
NCT01407029 is a clinical study titled "R3® Acetabular System in Patients With Degenerative Hip Disease". This is a prospective, non-randomized, consecutive series, multicenter clinical study that will include patients who will have total hip replacement with the R3 Acetabular System.
What is the current status of trial NCT01407029?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2009-10. Estimated completion is 2017-03-14.
Who is sponsoring clinical trial NCT01407029?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia